Last Round
Pre Seed
Apr 22, 2026
Total Funding Raised
$1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
BASE4 Biosciences operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Pre Seed round in April 2026.
BASE4 Biosciences is a biotech company that has developed a multi-omic platform using AI to analyze gene expression from a blood sample to determine the biological age of tissues and detect early signs of disease, with an initial focus on women's health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BASE4 Biosciences Comparables
Compare BASE4 Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vero Bioscience | 77% | |
| TruDiagnostic | 76% | |
| Regent Pacific Group Limited | 62% |
For institutional investors. Book with your work email.
BASE4 Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
BASE4 Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Itnig | Pre Seed |
| Kfund | Pre Seed |
| Baobab Ventures | Pre Seed |
| Masia | Pre Seed |
| K Fund | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
$1M raised in Pre Seed round.
For institutional investors. Book with your work email.
BASE4 Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BASE4 Biosciences's valuation, stock price, and market status.
Is BASE4 Biosciences a public or private company?
BASE4 Biosciences is a private company.
What is the current stock price of BASE4 Biosciences?
BASE4 Biosciences is a private company, so its shares have no public market price. Caplight tracks BASE4 Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BASE4 Biosciences worth (valuation)?
Valuation information for BASE4 Biosciences is not publicly available.
Can I buy BASE4 Biosciences stock?
BASE4 Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BASE4 Biosciences's last funding round?
BASE4 Biosciences's most recent funding round was Pre Seed on April 22, 2026.
Who are the main investors in BASE4 Biosciences?
Key investors in BASE4 Biosciences include Itnig, Kfund, Baobab Ventures, Masia, K Fund.
Will BASE4 Biosciences IPO soon?
No public IPO plans have been announced for BASE4 Biosciences.
How can I track BASE4 Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in BASE4 Biosciences's shares on secondary markets.